Author Interviews, Cancer Research / 01.08.2024
Common Blood Tests May Help Doctors Detect Unknown Cancers in Patients with Vague Symptoms
MedicalResearch.com Interview with:
[caption id="attachment_62690" align="alignleft" width="180"]
Dr. Meena Rafiq[/caption]
Dr Meena Rafiq | Academic GP & Clinical Research Fellow
FRACGP MRCGP MBBS BSc MSc
Epidemiology of Cancer and Healthcare Outcomes (ECHO) Group, UCL
Department of General Practice, The University of Melbourne
UCL Department of Behavioural Science and Health
MedicalResearch.com: What is the background for this study? What are the main findings?
Response: Almost all patients with cancer will first see their GP with symptoms and half of these patients will have vague, non-specific symptoms. As a GP I know it can be challenging to pick up patients with possible cancer in a 10 minute GP appointment, especially if they have vague non-specific symptoms. We know that many of these patients are already having blood tests done by their GP. So, we wanted to see if any of these blood tests could be used to help pick up with patients who see their GP with vague abdominal symptoms like abdominal pain and bloating are most likely to have cancer and need to be urgently referred.
Dr. Meena Rafiq[/caption]
Dr Meena Rafiq | Academic GP & Clinical Research Fellow
FRACGP MRCGP MBBS BSc MSc
Epidemiology of Cancer and Healthcare Outcomes (ECHO) Group, UCL
Department of General Practice, The University of Melbourne
UCL Department of Behavioural Science and Health
MedicalResearch.com: What is the background for this study? What are the main findings?
Response: Almost all patients with cancer will first see their GP with symptoms and half of these patients will have vague, non-specific symptoms. As a GP I know it can be challenging to pick up patients with possible cancer in a 10 minute GP appointment, especially if they have vague non-specific symptoms. We know that many of these patients are already having blood tests done by their GP. So, we wanted to see if any of these blood tests could be used to help pick up with patients who see their GP with vague abdominal symptoms like abdominal pain and bloating are most likely to have cancer and need to be urgently referred.
Joanna Gorgol[/caption]
Joanna Gorgol
PhD Student
University of Warsaw
MedicalResearch.com: What is the background for this study?
Response: People differ in the time when they prefer to wake up and fall asleep: some people prefer going to bed and waking up early, while others prefer later hours. Most of the population is somewhere between them. Research indicates that being a morning person is related to reporting higher satisfaction with life and conscientiousness. Studies also show the associations between being religious and having higher life satisfaction and conscientiousness. It seems that religiosity might mediate the relationship between morningness and higher life satisfaction. To better understand these associations we conducted two questionnaire-based studies of Polish adults, one with 500 participants and the other with 728 participants. All participants completed questionnaires measuring their chronotype, satisfaction with life, personality traits, and religiosity
Kenya Colvin[/caption]
Kenya Colvin, MBS
Department of Medical Education
Scranton, PA
MedicalResearch.com: What is the background for this study?
Response: Vaccine hesitancy is a major driver of COVID-19 vaccination disparities between minority and non-Hispanic White communities. Our goal was to understand what factors influenced vaccine hesitancy among individuals in Eastern Pennsylvania to identify more effective ways to promote vaccine uptake within minority communities.
Clare Jensen[/caption]
Clare Jensen
O’Haire Research Team
Center for the Human-Animal Bond
Purdue University College of Veterinary Medicine
MedicalResearch.com: What is the background for this study?
Response: Service dogs for PTSD are becoming more common and the evidence shows they can help improve mental health and quality of life for many veterans with PTSD. However, some veterans benefit more than others. Our research goal was to ask for the very first time: Why?
Prof. Rahi[/caption]
Prof. Jugnoo S Rahi
Professor of Ophthalmic Epidemiology and Honorary Consultant Ophthalmologist
NIHR Senior Investigator
Head,
Dr. Rettew[/caption]
David C. Rettew, MD
Child & Adolescent Psychiatrist
Associate Professor of Psychiatry and Pediatrics
University of Vermont Larner College of Medicine
MedicalResearch.com: What is the background for this study?
Response: Our group, the Wellness Environment Scientific Team at the University of Vermont, hadn’t planned to look at COVID at the outset of this study and instead were going to look at mental health and engagement in wellness activities in college students across a semester. The pandemic disrupted that plan when students were abruptly sent home but fortunately, they continued to do their daily app-based ratings of their mood, stress levels, and engagement in healthy activities. We then realized we had some interesting pre-COVID to COVID data that was worth exploring.



Dr. Piper[/caption]
Brian J. Piper, PhD, MS
Assistant Professor of Neuroscience
Department of Basic Sciences,
Geisinger Commonwealth School of Medicine,
Scranton PA 18509
MedicalResearch.com: What is the background for this study?
Response: The U.S. accounts for five percent of the world population but more than 92 percent of the world’s spending on pharmacotherapies for Attention Deficit Hyperactivity Disorder (ADHD). According to the 2011 National Survey of Children’s Health, ADHD increased to 11.0 percent of U.S. children, seven percent of girls and 15 percent of boys. Interestingly, ADHD rates were much lower among Hispanic children.
The 2013 revision to the Diagnostic and Statistical Manual of Mental Disorders broadened the criteria such that it became easier to diagnose adult ADHD. Together, we hypothesized that use of amphetamine (Adderall), methylphenidate (Ritalin), and lisdexamfetamine (Vyvanse) would be increasing. We also predicted that there would be some regional differences in stimulant use.
